LumaVida Women’s Health Institute is a specialist women’s-healthcare platform designed to deliver world-class obstetric, gynaecological, fertility and preventive care across South Africa. The Group will operate a network of premium specialist clinics, beginning with a Johannesburg flagship and rolling out to nine provincial clinics, partnering with private hospitals for surgery and deliveries while building standalone outpatient centres. Its brand promise, “illuminating every stage of a woman’s journey,” captures a model that owns the entire female healthcare lifecycle: teenage health, fertility, pregnancy, motherhood, menopause and healthy ageing.
The strategic rationale is to build something that does not yet exist in South Africa: a nationally branded, premium, integrated women’s-healthcare chain focused exclusively on the female healthcare journey. Today, women’s health is delivered by fragmented individual specialist practices operating within hospital groups. LumaVida’s positioning is deliberately between a traditional specialist practice and a private hospital group, in the founders’ words, “the Mediclinic of women’s health.”
Vision and mission
|
Vision |
To become Africa’s leading integrated women’s-healthcare brand. |
|
Mission |
To provide accessible, compassionate and technologically advanced healthcare for women at every stage of life. |
|
Ambition |
A nine-clinic national network, ~R180 million of revenue at a ~25% EBITDA margin by Year 5, and a strategic exit to a healthcare or investment group. |
The strategic model — three pillars
1. The integrated women’s-lifecycle model
Most gynaecologists focus mainly on pregnancy. LumaVida owns the whole lifecycle, teenage health, fertility, pregnancy, motherhood, menopause and healthy ageing, so that a patient stays within the LumaVida ecosystem across decades of her life. This lifecycle ownership deepens each patient relationship, smooths demand across services (fertility, maternity, gynaecology, longevity), and builds a recurring, loyal patient base that a single-service practice cannot.
2. A capital-light, asset-light platform
Unlike a hospital, LumaVida builds outpatient specialist centres, consultation rooms, ultrasound, minor-procedure rooms and a wellness lounge, and partners with private hospitals for surgery and deliveries on a revenue-share basis. This means the Group avoids the heavy capital cost of theatres and beds: a flagship clinic costs roughly R13–15 million to build and equip, and is profitable in its first year. The model is capital-efficient and scalable, and generates cash to help fund its own rollout.
3. A digital-and-membership platform
The LumaVida App, pregnancy tracker, appointment booking, medical records, AI health assistant, nutrition plans and specialist messaging, and the Women’s Wellness Membership create a recurring, technology-enabled relationship with patients beyond the clinic visit. The membership (a monthly subscription bundling annual screening, online consultations, health tracking and priority appointments) is a genuine innovation for the sector, adding predictable subscription revenue and a powerful patient-acquisition and retention engine.
Key findingThe opportunity is real — and gated by specialist supply
South Africa has strong and growing demand for specialist women’s health, but the binding constraint is the supply of specialists. Obstetrician-gynaecologists are concentrated in the metros, and fertility subspecialists are especially scarce, reproductive-medicine training is offered at only two to three centres nationally, and just 10–13% of the country’s assisted-reproduction need is currently met. LumaVida’s ambition to staff nine clinics with roughly 36 OB/GYNs plus fertility specialists, including in under-served provinces, is therefore the central execution challenge. The model’s technology and task-sharing help leverage each scarce specialist, but recruitment and retention are the make-or-break variables, addressed candidly throughout this Plan.
Revenue architecture
Revenue is diversified across five streams. Specialist consultations anchor the model at roughly 44% of revenue; diagnostics and ultrasound add about 16%; surgical procedures delivered through hospital partnerships contribute about 22%; fertility and reproductive medicine about 8%; and the membership and corporate-wellness programme about 10%. This mix balances high-volume consultation revenue with higher-value surgery and fertility work and the recurring, predictable membership subscription.
The five-year ambition
Within five years, LumaVida targets nine flagship clinics across South Africa’s provinces, revenue of approximately R180 million a year, a ~25% EBITDA margin (about R45 million), 10,000 wellness members, and a national brand recognised as the country’s premier women’s-health platform. The longer-term vision is a strategic exit, to a private-hospital group, a healthcare investment fund or an international women’s-health platform, achieved by building national scale and then integrating with a larger healthcare ecosystem. The immediate R25 million seed funds the Johannesburg flagship and the digital platform; this Plan sets out the full path to the national network.